437 related articles for article (PubMed ID: 33067172)
1. Cancer Plasticity: The Role of mRNA Translation.
Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell metabolism: Rewiring the mitochondrial hub.
Oliveira GL; Coelho AR; Marques R; Oliveira PJ
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
[TBL] [Abstract][Full Text] [Related]
3. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
[TBL] [Abstract][Full Text] [Related]
4. On translational regulation and EMT.
Evdokimova V; Tognon CE; Sorensen PH
Semin Cancer Biol; 2012 Oct; 22(5-6):437-45. PubMed ID: 22554796
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell plasticity: Impact on tumor progression and therapy response.
da Silva-Diz V; Lorenzo-Sanz L; Bernat-Peguera A; Lopez-Cerda M; Muñoz P
Semin Cancer Biol; 2018 Dec; 53():48-58. PubMed ID: 30130663
[TBL] [Abstract][Full Text] [Related]
6. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
[TBL] [Abstract][Full Text] [Related]
7. Translational control of breast cancer plasticity.
Jewer M; Lee L; Leibovitch M; Zhang G; Liu J; Findlay SD; Vincent KM; Tandoc K; Dieters-Castator D; Quail DF; Dutta I; Coatham M; Xu Z; Puri A; Guan BJ; Hatzoglou M; Brumwell A; Uniacke J; Patsis C; Koromilas A; Schueler J; Siegers GM; Topisirovic I; Postovit LM
Nat Commun; 2020 May; 11(1):2498. PubMed ID: 32427827
[TBL] [Abstract][Full Text] [Related]
8. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
9. The plasticity of mRNA translation during cancer progression and therapy resistance.
Fabbri L; Chakraborty A; Robert C; Vagner S
Nat Rev Cancer; 2021 Sep; 21(9):558-577. PubMed ID: 34341537
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Fitness and Plasticity in Cancer Progression.
McGuirk S; Audet-Delage Y; St-Pierre J
Trends Cancer; 2020 Jan; 6(1):49-61. PubMed ID: 31952781
[TBL] [Abstract][Full Text] [Related]
11. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
12. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat GR; Sethi I; Sadida HQ; Rah B; Mir R; Algehainy N; Albalawi IA; Masoodi T; Subbaraj GK; Jamal F; Singh M; Kumar R; Macha MA; Uddin S; Akil ASA; Haris M; Bhat AA
Cancer Metastasis Rev; 2024 Mar; 43(1):197-228. PubMed ID: 38329598
[TBL] [Abstract][Full Text] [Related]
13. Targeting the translation machinery in cancer.
Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
15. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
16. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment.
Bartish M; Abraham MJ; Gonçalves C; Larsson O; Rolny C; Del Rincón SV
Nat Rev Cancer; 2023 Jun; 23(6):408-425. PubMed ID: 37142795
[TBL] [Abstract][Full Text] [Related]
17. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
18. Deciphering Melanoma Cell States and Plasticity with Zebrafish Models.
Travnickova J; Patton EE
J Invest Dermatol; 2021 Jun; 141(6):1389-1394. PubMed ID: 33340501
[TBL] [Abstract][Full Text] [Related]
19. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
20. Noncoding RNAs in Cancer Cell Plasticity.
Xu J; Liu S
Adv Exp Med Biol; 2016; 927():173-89. PubMed ID: 27376735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
